Ana Maria Gonzalez-Angulo, MD, MSc

Dr. Gonzalez-Angulo attended medical school at the Universidad del Cauca in Colombia and moved to the U.S. to continue her training. She completed a residency in Internal Medicine at the Mount Sinai Medical Center in Miami, and a Fellowship in Medical Oncology at the Ochsner Clinic Foundation in New Orleans. She then went to the University of Texas MD Anderson Cancer Center to specialize in breast cancer as she was selected as the Susan G. Komen Breast Cancer Fellow. She remains on the MD Anderson faculty and works exclusively with breast cancer patients and in breast cancer research.

She is interested in aggressive types of breast cancer including triple receptor-negative disease. Her research focuses on mechanisms of resistance to standard breast cancer therapies, and on the development of markers to predict response to treatments using functional proteomics and mutation analyses. She is funded by the National Cancer Institute, American Society of Clinical Oncology, and the Commonwealth Foundation for Cancer Research.

She is the Chair of the Endocrine Resistance Working Group and a member of the Correlative Sciences Working Group for the Translational Breast Cancer Research Consortium, and a member of the Breast Cancer Committee of SWOG and of the BIG-NABCG Triple Negative Working Group. She serves as a member of the steering committee of The United States - Middle East Partnership for Breast Cancer Awareness and Research and the Partnership for Breast Cancer Awareness and Research of the Americas.